Skip to main content

Advertisement

Log in

Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study

  • Original Paper
  • Published:
Urolithiasis Aims and scope Submit manuscript

Abstract

Large cohort studies on whether any association existed between urological interventions for urolithiasis and the development of CKD are lacking. From claims data of the National Health Insurance (NHI) program of Taiwan, we identified 54,433 patients newly diagnosed with urolithiasis during 1998–2010. For each case, four individuals without urolithiasis were randomly selected and frequency matched by age, sex, and diagnosis year. Both groups were followed up until the end of 2010. Incident CKD events were identified by the International Classification of Diseases, Ninth Revision (ICD-9) code in the NHI registration database. The overall incidence of periodontal diseases was 1.85-fold greater in the urolithiasis group than in the comparison group (33.9 vs 18.3 per 10,000 person-years; 95 % confidence interval [CI] 1.81–1.90). Compared with the adjusted hazard ratios (aHRs) of nonurolithiasis patients, those of patients with urolithiasis increased with the number of medical visits (from 0.91 [95 % CI 0.83–1.00] to 10.6 [95 % CI 9.48–11.8]) and urological interventions (from 1.22 [95 % CI 1.10–1.35] to 86.4 [95 % CI 67.6–110.6]). The aHR was similar in different urological intervention methods, extracorporeal shock wave lithotripsy, ureteroscopy, percutaneous nephrostolithotomy, and open stone surgery. The urological intervention for urolithiasis is associated with an increased risk of CKD. We should be aware of the risk for CKD, especially in patients who have received multiple urological interventions and those elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

aHR:

Adjusted hazard ratio

CI:

Confidence interval

CKD:

Chronic kidney disease

ESRD:

End-stage renal disease

ICD-9-CM:

International Classification of Diseases, Ninth Revision, Clinical Modification

NHIRD:

National Health Insurance Research Database

LHID 2000:

Longitudinal Health Insurance Database 2000

References

  1. Yasui T, Iguchi M, Suzuki S, Kohri K (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71(2):209–213

    Article  PubMed  Google Scholar 

  2. Safarinejad MR (2007) Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res 35(2):73–82

    Article  PubMed  Google Scholar 

  3. Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713

    Article  CAS  PubMed  Google Scholar 

  4. Knoll T (2010) Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl 9(12):802–806

    Article  CAS  Google Scholar 

  5. Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci 105(28):9841–9846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, Monga M, Wilt TJ (2009) Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 56(1):72–80

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pearle MS, Calhoun EA, Curhan GC, Project UDoA (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857

    Article  PubMed  Google Scholar 

  8. Skolarikos A, Alivizatos G, de la Rosette J (2006) Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol 50(5):981–990

    Article  PubMed  Google Scholar 

  9. Paryani JP, Ather MH (2002) Improvement in serum creatinine following definite treatment of urolithiasis in patients with concurrent renal insufficiency. Scand J Urol Nephrol 36(2):134–136

    Article  CAS  PubMed  Google Scholar 

  10. Lifshitz DA, Lingeman JE, Zafar FS, Hollensbe DW, Nyhuis AW, Evan AP (1998) Alterations in predicted growth rates of pediatric kidneys treated with extracorporeal shockwave lithotripsy. J Endourol Soc 12(5):469–475

    Article  CAS  Google Scholar 

  11. Willis LR, Evan AP, Connors BA, Blomgren P, Fineberg NS, Lingeman JE (1999) Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol CJASN 10(8):1753–1762

    CAS  Google Scholar 

  12. Goel MC, Baserge NS, Babu RV, Sinha S, Kapoor R (1996) Pediatric kidney: functional outcome after extracorporeal shock wave lithotripsy. J Urol 155(6):2044–2046

    Article  CAS  PubMed  Google Scholar 

  13. Traxer O, Lottmann H, Archambaud F, Helal B, Mercier-Pageyral B (1999) Extracorporeal lithotripsy in children. Study of its efficacy and evaluation of renal parenchymal damage by DMSA-Tc 99 m scintigraphy: a series of 39 children. Arch de pediatrie : organe officiel de la Societe francaise de pediatrie 6(3):251–258

    Article  CAS  Google Scholar 

  14. El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol CJASN 7(9):1409–1415

    Article  PubMed  Google Scholar 

  15. Kummer AE, Grams M, Lutsey P, Chen Y, Matsushita K, Kottgen A, Folsom AR, Coresh J (2015) Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol CJASN 10(11):2023–2029

    Article  CAS  PubMed  Google Scholar 

  16. Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67(2):685–690

    Article  PubMed  Google Scholar 

  17. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56(2):571–580

    Article  CAS  PubMed  Google Scholar 

  18. Saucier NA, Sinha MK, Liang KV, Krambeck AE, Weaver AL, Bergstralh EJ, Li X, Rule AD, Lieske JC (2010) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55(1):61–68

    Article  PubMed  Google Scholar 

  19. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739–1742

    Article  PubMed  Google Scholar 

  20. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2014) Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol 9(3):506–512

    Article  PubMed  Google Scholar 

  21. Gambaro G, Favaro S, D’Angelo A (2001) Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37(2):233–243

    Article  CAS  PubMed  Google Scholar 

  22. Stankus N, Hammes M, Gillen D, Worcester E (2007) African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35(2):83–87

    Article  PubMed  Google Scholar 

  23. Siegel C (2012) Re: Clinical characteristics of potential kidney donors with asymptomatic kidney stones. J Urol 188(3):849–850

    Article  PubMed  Google Scholar 

  24. Strang AM, Lockhart ME, Amling CL, Kolettis PN, Burns JR (2008) Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J Urol 179(3):832–836

    Article  PubMed  Google Scholar 

  25. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287–e5294

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chia-Hung Kao.

Ethics declarations

Funding

This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.

Conflict of interest

The authors declare no conflicts of interest.

Ethnic approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Review Board of China Medical University (CMUH104-REC2-115).

Informed consent

Because NHIRD database was de-identification, thus this study was exempted from informed consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, SY., Lin, CL., Chang, CH. et al. Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study. Urolithiasis 45, 465–472 (2017). https://doi.org/10.1007/s00240-016-0929-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-016-0929-y

Keywords

Navigation